BioCryst Pharma (NASDAQ:BCRX) reported its Q1 earnings results on Wednesday, May 3, 2023 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

BioCryst Pharma beat estimated earnings by 6.67%, reporting an EPS of $-0.28 versus an estimate of $-0.3.

Revenue was up $18.86 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.21 which was followed by a 13.08% increase in the share price the next day.

Here's a look at BioCryst Pharma's past performance:

To track all earnings releases for BioCryst Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.